Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-29 @ 11:18 AM
Study NCT ID:
NCT03186495
Status:
COMPLETED
Last Update Posted:
2020-04-17
First Post:
2017-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-12
First Submit QC Date:
None
Study First Post Date:
2017-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-16
Last Update Post Date:
2020-04-17
Last Update Post Date Type:
ACTUAL